Cuijian Zhang
Papers
3
Total Citations
81
H-Index
2
About
Dr. Cuijian Zhang is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of robotic-assisted kidney surgery. His primary research focus is the clinical validation and advancement of novel surgical robotic systems, particularly the domestically developed KangDuo Surgical Robot (KD-SR). Dr. Zhang’s most significant contribution is leading the first double-center prospective randomized controlled noninferiority trial comparing the KD-SR against the established da Vinci Si system for robot-assisted partial nephrectomy (RAPN). This landmark 2022 study, which has garnered 54 citations, provided rigorous evidence that the KD-SR is a safe and effective alternative, marking a critical step toward accessible, high-quality robotic surgery. He further demonstrated the system’s versatility by pioneering its use in retroperitoneal partial nephrectomy, as detailed in his 2021 work (25 citations). By systematically proving the noninferiority of a new generation of surgical robots, Dr. Zhang is directly addressing barriers of cost and availability, potentially democratizing access to advanced minimally invasive procedures. His work stands at the intersection of surgical innovation and clinical translation, making him a key figure in the future of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3